Demographic data of the study population (n=number of patients)
| Demographic data | AID (n=804) | IBD (n=53) | IBS (n=205) | Total (n=1062) |
|---|---|---|---|---|
| Age, years (mean±SD) | 43.1±18.3 | 46.9±16.5 | 42.5±15.9 | 43.2±17.8 |
| Female, n (%) | 441 (55.0) | 31 (58.5) | 140 (68.3) | 612 (57.7) |
| Body weight, kg (mean±SD) | 74.4±15.8 | 72.9±12.8 | 71.4±15.5 | 73.8±15.7 |
| Body temperature, °C (mean±SD) | 36.9±0.6 | 36.8±0.6 | 36.8±0.5 | 36.9±0.6 |
| Risk factors for acute diarrhoea | ||||
| Alcohol, n (%) | 90 (11.3) | 8 (15.1) | 38 (18.7) | 136 (12.9) |
| Travelling, n (%) | 72 (9.1) | 5 (9.4) | 32 (15.7) | 109 (10.4) |
| Hormonal imbalance, n (%) | 46 (5.8) | 4 (7.5) | 21 (10.3) | 71 (6.7) |
| Drug intake, n (%) | 57 (7.2) | 11 (20.8) | 33 (16.3) | 101 (9.6) |
| Food intolerance, n (%) | 101 (12.7) | 14 (26.4) | 109 (53.7) | 224 (21.3) |
| Smoking, n (%) | 206 (25.9) | 9 (17.0) | 56 (27.5) | 271 (25.8) |
| Metabolic disorder, n (%) | 88 (11.1) | 5 (9.4) | 10 (4.9) | 103 (9.8) |
| Stress, n (%) | 282 (35.3) | 35 (66.0) | 155 (76.0) | 472 (44.7) |
| Concomitant illness, n (%) | 232 (54.8) | 36 (8.5) | 155 (36.6) | 423 (39.8) |
| Concomitant medication, n (%) | 240 (52.3) | 50 (10.9) | 169 (36.8) | 459 (43.2) |
| Treatment chosen by physician | ||||
| Monotreatment, n (%)* | 524 (65.2) | 21 (39.6) | 86 (42.0) | 631 (59.4) |
| Add-on treatment, n (%)* | 144 (17.9) | 28 (52.8) | 82 (40.0) | 254 (23.9) |
| Other therapy | 136 (16.9) | 4 (7.5) | 37 (18.0) | 177 (16.7) |
*Treatment with the herbal preparation.
AID, acute inflammatory disorders; IBD, inflammatory bowel diseases; IBS, irritable bowel syndrome.